Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6067
Source ID: NCT00477581
Associated Drug: Exenatide
Title: A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG: exenatide|DRUG: sitagliptin
Outcome Measures: Primary: Effect of Exenatide on postprandial glucose, To compare the effect of exenatide to that of sitagliptin on 2-hour postprandial glucose in subjects with type 2 diabetes mellitus, 28 days | Secondary: Assessment of effect of exenatide to the effect of sitagliptin the acetaminophen absorption test, and 6-point self-monitored blood glucose (SMBG) profiles, To compare the effect of exenatide to the effect of sitagliptin on the following endpoints in subjects with type 2 diabetes mellitus: postprandial glucose, insulin, insulin secretion rate, glucagon, and triglycerides; gastric emptying, as assessed by the acetaminophen absorption test, and 6-point self-monitored blood glucose (SMBG) profiles, 28 days
Sponsor/Collaborators: Sponsor: AstraZeneca | Collaborators: Eli Lilly and Company
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 102
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2007-05
Completion Date: 2007-09
Results First Posted:
Last Update Posted: 2015-08-26
Locations: Research Site, Los Angeles, California, United States|Research Site, Spring Valley, California, United States|Research Site, Miami, Florida, United States|Research Site, Pembroke Pines, Florida, United States|Research Site, Chicago, Illinois, United States|Research Site, Indianapolis, Indiana, 46260, United States|Research Site, Indianapolis, Indiana, United States|Research Site, Detroit, Michigan, United States|Research Site, Butte, Montana, United States|Research Site, Winston-Salem, North Carolina, United States|Research Site, Cincinatti, Ohio, United States|Research Site, Marion, Ohio, United States|Research Site, Eugene, Oregon, United States|Research Site, Portland, Oregon, United States|Research Site, Charleston, South Carolina, United States|Research Site, Greer, South Carolina, United States|Research Site, Austin, Texas, United States|Research Site, Corpus Christi, Texas, United States|Research Site, San Antonio, Texas, United States
URL: https://clinicaltrials.gov/show/NCT00477581

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress